GxP/GMP and its Consequences for Quality Management, Quality Audit, Documentation, and Information Technology Systems

Course

In New York City (USA)

Save 93%
£ 79.94 VAT inc.

*Indicative price

Original amount in USD:

$ 100 $ 1,495

Description

  • Type

    Seminar

  • Level

    Beginner

  • Location

    New york city (USA)

  • Duration

    2 Days

Course "GxP/GMP and its Consequences for Quality Management, Quality Audit, Documentation, and Information Technology Systems" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion.
Overview:
GxP/GMP regulations are required to be used in regulated industries such as food and beverages, pharmaceutical, medical devices, and cosmetics. GMP regulations describe required quality management system for production and testing of products in these regulated industries. The purpose of the GMP regulations is to ensure that a product is safe and meets its intended use.
Quality management system ensures that a product is safe and meets its intended use. Quality management system has four main components: quality planning, quality assurance, quality control, and quality improvement.
Quality audit is the process of systematic inspection of quality management system which is carried out by an internal or external auditor or an audit team. It is an important part of organization's quality management system and is the major part of GxP/GMP regulations.
CAPA - Corrective and Preventive Action plan. It is required for FDA compliance in case of specification situations or other deviations.
Documentation is a critical tool for ensuring GxP/GMP compliance.
In the regulated environment which must be GxP/GMP compliant, document control is the cornerstone of the quality system. It is so important that if an external audit identifies deficiencies in the document control system, the entire organization can be shut down.

Facilities

Location

Start date

New York City (USA)
See map
Sheraton JFK Airport Hotel 132-26 South Conduit Avenue Jamaica, New York 11430 United States, 11430

Start date

On request

About this course

• Quality Assurance
• Documentation Managers
• Records Managers
• Document Control
• Compliance
• Medical Affairs
• IT

Questions & Answers

Add your question

Our advisors and other users will be able to reply to you

Who would you like to address this question to?

Fill in your details to get a reply

We will only publish your name and question

Reviews

Subjects

  • Quality Audit
  • Compliance
  • Audit
  • Quality
  • Systems
  • Technology
  • Quality management
  • Quality Training
  • Regulations
  • GMP

Course programme

Agenda:
Day 1 Schedule

  • Part I: Japan Regulatory Compliance

Lecture 1:
  • Japan's Regulatory Structure for the Life Science Product Industries
  • Country Healthcare System
  • Regulatory Framework: Key Agencies Involved / Reporting Structure
  • MHLW (Ministry of Health, Labor and Welfare)
  • PMDA (Pharmaceutical and Medical Device Agency)
  • Agency Consulting Committees
  • Patent System
  • Pharmaceutical Affairs Law (PAL) → Pharmaceuticals & Medical Device Law (PMDL)

Lecture 2:
  • Beginning Your Company Involvement in Japan
  • Local Office and Personnel Requirements
  • Language Requirements & Translations
  • License Types
  • Options for Importers / Overseas Manufacturers
Lecture 3:
  • Objectives of the Rules Governing Medicinal Procedures
  • Life Science Regulations and the Regulatory Processes in Japan
  • Conducting Clinical Trials
  • New Product Registrations
  • Handling of Risk Management
  • Post-Marketing Requirements: Variations / amendments, Safety Reporting, Renewals

Lecture 4:
  • Japan's Use of ICH Standards / Principles
  • GCP
  • GMP
  • CTD / e-CTD Submissions

Lecture 5:
  • Starting-Up and Conducting Clinical Trials
  • Who can conduct Clinical Trials?
  • When are they needed?
  • Start-up Process & Timelines
Day 2 Schedule

  • Part II:

Lecture 1:
  • Marketing Authorization Processes - Product Registrations / Licensing
  • Drugs
  • Medical Devices
  • Biologics
  • Combination Products
  • Drug / Device Master File (DMF) Use in Japan
  • Labeling Requirements
  • Packaging Information Leaflets

Lecture 2:
  • Variations: Changes to Marketed Products
  • Types of Variations & Dossier Maintenance Expectations

Lecture 3:
  • License Renewals
  • Process and timing for Renewing Licenses

Lecture 4:
  • Comparing and Contrasting Japan's Procedures vs. U.S. FDA
  • Comparison of Processes
  • Expected Timelines

Lecture 5:
  • How and When to Influence the Regulatory Process
  • The Do's and Don'ts of Regulatory Involvement in Japan
  • Utilizing Local Regulatory Resources

GxP/GMP and its Consequences for Quality Management, Quality Audit, Documentation, and Information Technology Systems

£ 79.94 VAT inc.

*Indicative price

Original amount in USD:

$ 100 $ 1,495